Articles

Schaeffer Nonresident Senior Fellow Bob Kocher discusses the elements of CMMI’s new Enhancing Oncology Model, explores its likelihood of success, and discusses its relative shortcomings in a new JAMA Health Forum Viewpoint.

Letters successfully encouraged clinicians to check patients’ prescribing records, says study co-author Mireille Jacobson.

CTRL is seeking proposals for pilot projects that test strategies and solutions designed to address barriers to recruitment for Alzheimer’s disease clinical trials.

Those clinicians who received the letter wrote 7% fewer prescriptions than clinicians who hadn’t received the notification.

There is no excerpt because this is a protected post.

Social scientists are uniquely poised to evaluate the implications of Alzheimer’s costs, yet they often lack knowledge of the biomedical foundations of the disease.

If saving lives is the objective, then logic, clinical evidence and compassion dictate that Medicare should pay for preventing and treating obesity, starting now.

A USC-developed interactive mapping tool shows the location of every pharmacy in the United States — and which neighborhoods are “pharmacy deserts.”

Researchers analyzed the effects of clinic ownership and dialysis timing on patient outcomes.

The law’s price controls do away with incentives for research and development of life-saving drugs.